A case of acute promyelocytic leukemia with pericardial effusion successfully managed with colchicine during ATO administration-Reference-Cited by-同舟云学术

A case of acute promyelocytic leukemia with pericardial effusion successfully managed with colchicine during ATO administration

Published:2024-02-20 Issue:4 Volume:103 Page:1409-1410
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Goto Takayuki,Nakamura Nobuhiko,Suzaki Tomomi,Shimazu Ryoma,Kaneda Yuto,Ikoma Yoshikazu,Matsumoto Takuro,Nakamura Hiroshi,Kanemura Nobuhiro,Shimizu Masahito

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00277-024-05660-9.pdf

Reference9 articles.

1. Lo-Coco F, Avvisati G, Vignetti M et al (2013) Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med 369:111–121. https://doi.org/10.1056/NEJMoa1300874

2. Vineetha VP, Raghu KG (2019) An overview on Arsenic Trioxide-Induced Cardiotoxicity. Cardiovasc Toxicol 19:105–119. https://doi.org/10.1007/s12012-018-09504-7

3. Adler Y, Charron P, Imazio M et al (2015) 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the Task Force for the diagnosis and management of Pericardial diseases of the European Society of Cardiology (ESC)endorsed by: the European Association for Cardio-thoracic surgery (EACTS). Eur Heart J 36:2921–2964. https://doi.org/10.1093/eurheartj/ehv318

4. Imazio M, Cecchi E, Demichelis B et al (2008) Myopericarditis versus viral or idiopathic acute pericarditis. Heart 94:498–501. https://doi.org/10.1136/hrt.2006.104067

5. Soignet SL, Frankel SR, Douer D et al (2001) United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 19:3852–3860. https://doi.org/10.1200/JCO.2001.19.18.3852